EarlyBirds Helping in the Rapidly Emerging Technologies for Health Diagnostics, Pharma and Biotech Industries

Forde, April 19, 2022 (GLOBE NEWSWIRE) -- EarlyBirds, is an Australian company that manages a business to business (B2B) open ecosystem that provides a way for early adopters, innovators, and subject matter experts (SMEs) to meet and create partnerships to speed up technology advancement and adoption. They would like to inform everyone about helping the health care industry in their search for the appropriate solutions after the pandemic has stimulated the rapid adoption of new technologies to help them respond to the intense demand created by the crisis.

Digital Disruption in Health, BioTech and Pharma Sectors

Future Health Technologies
Future Health Technologies

For instance, the pandemic has caused a spike in the demand for diagnostics and PPE and this has caused businesses in this particular health care segment to look for solutions through technological innovations to grow their business rapidly and hopefully catch up with the significant rise in demand for their products. Furthermore, there has been an increasing popularity of healthcare wearable devices, a growing awareness of the need for personalised medicine, and an increasing integration of artificial intelligence (AI). This has significantly impacted diagnostic centres, hospitals, laboratories, and the end users.

Meanwhile, according to Forbes, biotech and pharma companies have been relying on their own R&D efforts but this has not been sufficient and they are now turning to strategic initiatives and towards their supply chain and manufacturing partners to streamline their processes. This industry has also heavily increased its dependence on data analytics to boost drug development, drug manufacturing, and for anticipating the patient response to a particular medication and for evaluating diagnostic results.

Taking Advantage of Emerging Technologies

Health care professionals are also taking advantage of machine learning algorithms to analyze why certain medication are effective in the effort to help improve future drug development efforts. AI is also being used to evaluate tests and medical records and monitor the impact of various therapies on groups of patients over time. Researchers are training machines to recognise certain patterns that show how a person will metabolise drugs, allowing them to predict more accurately the effectiveness of a particular drug.

Healthcare providers are also using advanced technology to help enhance patient outcomes, particularly with regards to the management of chronic and acute disease. For instance, virtual care programs and telemedicine are being used by physicians to monitor their patients remotely using sensors that track their vital signs, medical records, and other personal information.